Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer

Published:2024-08-01 Issue:32 Volume:18 Page:21156-21170
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Lu Haibin¹,Tong Weifang²,Jiang Meixu¹,Liu Huimin¹,Meng Chen¹,Wang Kai¹,Mu Xupeng³^ORCID

Affiliation:

1. Jilin University School of Pharmaceutical Sciences, Changchun 130021, China

2. Department of Otolaryngology Head and Neck Surgery, The Second Hospital of Jilin University, Changchun 130041, China

3. Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun 130033, China

Funder

Jilin Provincial Scientific and Technological Development Program

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c04024

Reference50 articles.

1. Platinum-based drugs for cancer therapy and anti-tumor strategies

2. Cisplatin: The first metal based anticancer drug

3. Cisplatin in cancer therapy: Molecular mechanisms of action

4. Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway

5. Platinum-based chemotherapy via nanocarriers and co-delivery of multiple drugs

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP